8 out of 10 Hodgkin’s lymphoma patients are cured with proper diagnosis and treatment Published on 10/09/2020 One of the population subgroups most affected by Hodgkin's lymphoma, of which about 30 cases per million inhabitants are diagnosed annually in our country, is young people between 15 and 35 years of age
MD Anderson Cancer Center Madrid – Hospiten launches a new Haematopoietic Transplant Unit Published on 27/02/2020 After more than 15 years of experience in autologous and allogeneic transplants, MD Anderson Cancer Madrid has launched a new Haematopoietic Transplant Unit with a view to enhancing and developing the transplant programme and offering CAR-T therapy.
IDH inhibitors give very positive results in relapsed acute myeloblastic leukemia patients with the mutation Published on 08/10/2019 Acting on this therapy target would give favorable results in both monotherapy and in combination with other agents, thus improving life expectancy of patients with acute myeloblastic leukemia (AML)